Ian F. Smith
2015
In 2015, Ian F. Smith earned a total compensation of $9M as EVP & Chief Operating Officer and CFO at Vertex Pharmaceuticals, a 41% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $832,500 |
|---|---|
| Option Awards | $5,199,586 |
| Salary | $701,796 |
| Stock Awards | $2,258,991 |
| Other | $13,110 |
| Total | $9,005,983 |
Smith received $5.2M in option awards, accounting for 58% of the total pay in 2015.
Smith also received $832.5K in non-equity incentive plan, $701.8K in salary, $2.3M in stock awards and $13.1K in other compensation.
Rankings
In 2015, Ian F. Smith's compensation ranked 632nd out of 13,638 executives tracked by ExecPay. In other words, Smith earned more than 95.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 632 out of 13,638 | 95th |
Division Manufacturing | 219 out of 5,190 | 96th |
Major group Chemicals And Allied Products | 80 out of 1,854 | 96th |
Industry group Drugs | 61 out of 1,528 | 96th |
Industry Pharmaceutical Preparations | 49 out of 1,182 | 96th |
Source: SEC filing on April 28, 2017.
Smith's colleagues
We found four more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2015.